Asia Pacific Airway Management Devices Market

The airway management devices market in Asia Pacific is expected to grow from US$ 391.18 million in 2022 to US$ 597.49 million by 2028. It is estimated to grow at a CAGR of 7.3% from 2022 to 2028.

Rising Research and Development Activities and Collaborations Among Market Players

Medical device research and development are considered highly capital-intensive and fraught with enormous risks. R&D is an essential step, after which the best ideas are converted into the best products. A thriving R&D ecosystem can become the perfect nurturing ground for developing competitive and top-of-the-line products, from conceiving an ideal product design to new product development, prototyping, validation, and testing. To produce innovative products, MedTech companies are investing a huge part of revenue in R&D. With a continued focus on developing and commercializing new, innovative products and solutions, the company aims to improve patient outcomes, help physicians and providers better manage chronic disease, and lower healthcare costs. Furthermore, there have been several strategic collaborations among market players to share resources such as research, manufacturing, design, and technology for developing new and innovative products. The market players are mostly involved in joint ventures, partnerships, and mergers & acquisitions, which is likely to promote market growth.

A few strategic initiatives taken by the market players are as follows:

In May 2021, Teleflex entered into a definitive agreement to sell certain product lines within the global respiratory product portfolio to Medline Industries Inc.

In May 2021, Medline signed a definitive agreement to acquire select assets under the Hudson RCI brand of Teleflex’s Respiratory business.

Market Overview

The Asia Pacific airway management devices market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific is expected to be the fastest-growing region, with China accounting for the major market share; however, India is expected to develop at a significant CAGR during the forecast period. The market growth in the region is attributed to the increasing prevalence of respiratory disorders such as COPD, asthma, cystic fibrosis, and emphysema and the surging geriatric population, which is susceptible to such conditions. Moreover, the COVID-19 pandemic further created the demand for airway management devices for the management of COVID-19 patients on a large scale. Additionally, the increase in COVID-19 cases led to the increased demand and production of single-use airway management devices to prevent the further spread of infection. All these factors are boosting the growth of the airway management devices market in the region.

 Asia Pacific Airway Management Devices Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Airway Management Devices Strategic Insights

Strategic insights for the Asia Pacific Airway Management Devices provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Airway Management Devices Report Scope

Asia Pacific Airway Management Devices Regional Insights

The geographic scope of the Asia Pacific Airway Management Devices refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Asia Pacific Airway Management Devices Market Segmentation

The Asia Pacific airway management devices market is segmented into product and end user.

• Based on product, the market is segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, and others. The infraglottic devices segment registered the largest market share in 2022.
• Based on end user, the market is categorized into hospitals, ambulatory surgical care centers, and others. The hospitals segment held the largest market share in 2022. 
• Based on country, the market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC. China dominated the market in 2022.

Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Ambu A/S; Medline Industries, Inc.; Koninklijke Philips N.V.; ARMSTRONG MEDICAL; and Cook Medical LLC are among the leading companies operating in the airway management devices market in the region.